Serotonin Syndrome Presenting as a Posterior Reversible Encephalopathy Syndrome

Posterior reversible encephalopathy syndrome (PRES) is a neurological syndrome characterized by an altered level of consciousness, headaches, seizure, and visual changes. PRES has several different etiologies, including malignant hypertension, eclampsia, and certain medications. Here, we describe a...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Case reports in neurology Ročník 12; číslo 1; s. 63 - 68
Hlavní autori: Malik, Muhammad Taimur, Majeed, Mohammad Faraz, Zand, Ramin
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Basel, Switzerland S. Karger AG 01.01.2020
Karger Publishers
Predmet:
adverse reactions
Antibiotics
Antidepressants
Blood pressure
Case reports
cerebral vasoconstriction
Convulsions & seizures
Eclampsia
Emergency medical care
Headaches
Hypertension
Lupus
Magnetic resonance imaging
Pathogenesis
posterior reversible encephalopathy syndrome
Serotonin
serotonin syndrome
Single Case – General Neurology
Single Case − General Neurology
venlafaxine
Venlafaxine
Adverse reactions
Cerebral vasoconstriction
Serotonin syndrome
Posterior reversible encephalopathy syndrome
ISSN:1662-680X, 1662-680X
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Posterior reversible encephalopathy syndrome (PRES) is a neurological syndrome characterized by an altered level of consciousness, headaches, seizure, and visual changes. PRES has several different etiologies, including malignant hypertension, eclampsia, and certain medications. Here, we describe a 41-year-old woman who presented with altered mental status. She had a preliminary diagnosis of serotonin syndrome as she was on many different serotonin-sparing agents, but her imaging findings were consistent with PRES. After her medications were reviewed and the causative agent was removed, the patient’s neurological exam and imaging findings improved, and she returned to her baseline. To our knowledge, this is a unique case of PRES caused by serotonin syndrome secondary to venlafaxine usage.
Bibliografia:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
content type line 23
ISSN:1662-680X
1662-680X
DOI:10.1159/000505907